Literature DB >> 9294778

Localization and postoperative follow-up of a bronchial carcinoid tumor causing Cushing's syndrome by 111In-DTPA labelled octreotide scintigraphy.

F Fernandez-Fernandez1, I Halperin, J M Manzanares, L Flores, F Lomeña, E Vilardell.   

Abstract

Bronchial carcinoid tumor is the most frequent occult source of ectopic ACTH-dependent Cushing's syndrome, but its initial localization may be very difficult, as well as its postoperative follow-up. We here present the case of a 21-year-old man with Cushing's syndrome and biochemical findings suggesting an ectopic source of ACTH (lack of inhibition of cortisol after overnight 8-mg dexamethasone suppression test, and lack of response to h-CRH challenge). Chest CT-scan showed a node adjacent to the left lung hilium whose nature was confirmed by uptake of 111Indium-DTPA labelled octreotide scintigraphy. Surgical resection of the tumor consisted in an upper lobectomy of the left lung. Microscopic examination identified a typical carcinoid tumor. After surgery pituitary-adrenal function normalized and a second scintigraphy offered additional data on the absence of tumor remnants.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9294778     DOI: 10.1007/BF03350311

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  16 in total

1.  Additive effect of ketoconazole and octreotide in the treatment of severe adrenocorticotropin-dependent hypercortisolism.

Authors:  F Vignati; P Loli
Journal:  J Clin Endocrinol Metab       Date:  1996-08       Impact factor: 5.958

2.  Diagnosis and management of ACTH-dependent Cushing's syndrome: comparison of the features in ectopic and pituitary ACTH production.

Authors:  T A Howlett; P L Drury; L Perry; I Doniach; L H Rees; G M Besser
Journal:  Clin Endocrinol (Oxf)       Date:  1986-06       Impact factor: 3.478

Review 3.  Bronchopulmonary carcinoids associated with Cushing's syndrome--report of a case and an overview of the literature.

Authors:  J Hofland; A J Schneider; M A Cuesta; S Meijer
Journal:  Acta Oncol       Date:  1993       Impact factor: 4.089

4.  Localization of adrenocorticotropic hormone-secreting bronchial carcinoid tumor by somatostatin-receptor scintigraphy.

Authors:  M Weiss; A Yellin; M Husza'r; Z Eisenstein; J Bar-Ziv; Y Krausz
Journal:  Ann Intern Med       Date:  1994-08-01       Impact factor: 25.391

Review 5.  The Cushing syndrome: an update on diagnostic tests.

Authors:  T B Kaye; L Crapo
Journal:  Ann Intern Med       Date:  1990-03-15       Impact factor: 25.391

6.  A comparison of the standard high dose dexamethasone suppression test and the overnight 8-mg dexamethasone suppression test for the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.

Authors:  H L Dichek; L K Nieman; E H Oldfield; H I Pass; J D Malley; G B Cutler
Journal:  J Clin Endocrinol Metab       Date:  1994-02       Impact factor: 5.958

Review 7.  Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients.

Authors:  E P Krenning; D J Kwekkeboom; W H Bakker; W A Breeman; P P Kooij; H Y Oei; M van Hagen; P T Postema; M de Jong; J C Reubi
Journal:  Eur J Nucl Med       Date:  1993-08

Review 8.  Bronchial carcinoid tumors.

Authors:  D G Davila; W F Dunn; H D Tazelaar; P C Pairolero
Journal:  Mayo Clin Proc       Date:  1993-08       Impact factor: 7.616

9.  The radiological investigation of occult ectopic ACTH-dependent Cushing's syndrome.

Authors:  J M Vincent; P J Trainer; R H Reznek; A J Marcus; J E Dacie; P Armstrong; G M Besser
Journal:  Clin Radiol       Date:  1993-07       Impact factor: 2.350

10.  Successful localization of an occult ACTH-secreting bronchial carcinoid tumour with 111indium-DTPA labelled octreotide.

Authors:  S Tsagarakis; C Giannakenas; P J Vassilakos; O Platis; I Belenis; J Kaskarelis; D Rontoyianni; N Thalassinos
Journal:  Clin Endocrinol (Oxf)       Date:  1995-12       Impact factor: 3.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.